Details for New Drug Application (NDA): 040907
✉ Email this page to a colleague
The generic ingredient in HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Summary for 040907
Tradename: | HYDROCHLOROTHIAZIDE |
Applicant: | Unichem |
Ingredient: | hydrochlorothiazide |
Patents: | 0 |
Pharmacology for NDA: 040907
Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for 040907
Suppliers and Packaging for NDA: 040907
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HYDROCHLOROTHIAZIDE | hydrochlorothiazide | TABLET;ORAL | 040907 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-128 | 29300-128-01 | 100 TABLET in 1 BOTTLE (29300-128-01) |
HYDROCHLOROTHIAZIDE | hydrochlorothiazide | TABLET;ORAL | 040907 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-128 | 29300-128-05 | 500 TABLET in 1 BOTTLE (29300-128-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Aug 15, 2008 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Aug 15, 2008 | TE: | AB | RLD: | No |
Complete Access Available with Subscription